Table 3.

Changes in expression profiles of hsa-miR-373-5p and hsa-miR-1827 in keratinocyte cultures exposed to LPS and adalimumab compared to controls (p < 0.05)

miRNA	HaCaT with LPS	HaCaT with LPS and adalimumab
	H_8 vs. C	H_2 vs. C	H_8 vs. C	H_24 vs. C
hsa-miR-373-5p	(+)2.04 ±0.11	(+)3.19 ±0.34	(+)4.11 ±.0.65	(+)2.01 ±0.12
hsa-miR-1827	(+)1.98 ±0.13	(+)2.65 ±0.34	(+)2.01 ±0.34	(+)2.99 ±0.31

C – control culture, H_2, H_8, H_24 – time of exposure of keratinocytes to LPS or adalimumab.